Impact of C-Reactive Protein Kinetics on Survival of Patients with Metastatic Renal Cell Carcinoma
- 1 May 2009
- journal article
- Published by Elsevier in European Urology
- Vol. 55 (5) , 1145-1154
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- C‐reactive protein level predicts prognosis in patients with muscle‐invasive bladder cancer treated with chemoradiotherapyBJU International, 2008
- Evaluation of an inflammation‐based prognostic score in patients with metastatic renal cancerCancer, 2007
- Increased preoperative serum C‐reactive protein level predicts a poor prognosis in patients with localized renal cell carcinomaBJU International, 2006
- Impact of thrombocytosis and C‐reactive protein elevation on the prognosis for patients with renal cell carcinomaInternational Journal of Urology, 2006
- Prognostic factors in metastatic renal cell carcinoma: metastasectomy as independent prognostic variableBritish Journal of Cancer, 2006
- Cancer Incidence and Incidence Rates in Japan in 2000: Estimates Based on Data from 11 Population-Based Cancer RegistriesJapanese Journal of Clinical Oncology, 2006
- Down-regulation of vascular endothelial growth factor in renal cell carcinoma cells by glucocorticoidsMolecular and Cellular Endocrinology, 2004
- Randomized Study of High-Dose and Low-Dose Interleukin-2 in Patients With Metastatic Renal CancerJournal of Clinical Oncology, 2003
- Interleukin-6 and renal cell cancer: Production, regulation, and growth effectsCancer Immunology, Immunotherapy, 1992
- Interleukin‐6 (IL‐6) functions as an in vitro autocrine growth factor in renal cell carcinomasFEBS Letters, 1989